Re-analysis of data on use of breast cancer medicine Tyverb following treatment with trastuzumab

View source ↗

Summary

EMA re-analyzed data on using Tyverb (lapatinib) after trastuzumab treatment for breast cancer to clarify outcomes and potential implications for sequencing of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Tyverb (lapatinib)